Dr. Jeffrey F. Scott is a board-certified Mohs micrographic surgeon and board-certified dermatologist in the Baltimore area who focuses on Mohs micrographic surgery, complex cutaneous reconstruction after Mohs surgery, the surgical management of high-risk non-melanoma skin cancer, melanoma, and rare skin cancers, and the management of skin cancer in transplant recipients. He serves as the Director of the Cutaneous Surgery and Oncology Unit at the Johns Hopkins School of Medicine.
Dr. Scott received dual undergraduate degrees in molecular and cell biology and in physiology and neurobiology from the University of Connecticut. He earned his M.D. and his M.H.S. from the Yale School of Medicine. He completed his residency in dermatology and fellowship in micrographic surgery and dermatologic oncology at Case Western Reserve University School of Medicine. Dr. Scott joined the Johns Hopkins faculty in 2019 as an Assistant Professor of Dermatology. Prior to joining Johns Hopkins, Dr. Scott was an Assistant Professor of Dermatology at Case Western Reserve University.
His research interests include complex cutaneous reconstruction, defining value in Mohs micrographic surgery, assessing patient-reporting outcomes in skin cancer treatment, and advancing evidence-based management of high-risk and rare skin cancers.
Dr. Scott has published over 100 articles in the peer-reviewed literature and was recognized by the American Society for Dermatologic Surgery with a Young Investigators Writing Competition Award in 2019. He is a member of several professional organizations, including the American College of Mohs Surgery (ACMS), the American Society for Dermatologic Surgery (ASDS), the American Academy of Dermatology (AAD), the Association of Professors of Dermatology (APD), and the Maryland Dermatologic Society (MDS). He also serves as a member on the non-melanoma skin cancer panel for the National Comprehensive Cancer Center (NCCN), tasked with updating multidisciplinary consensus guidelines on the management of basal cell carcinoma, cutaneous squamous cell carcinoma, Merkel cell carcinoma, and dermatofibrosarcoma protuberans (DFSP). Dr. Scott has been recognized on the local level as a participant in the Johns Hopkins Junior Faculty Leadership Program and Johns Hopkins Ambulatory Management Program, and on a national level as a participant in the ACMS Mohs Surgeons Leading the Future program and the ASDS Future Leaders Network.